Table 1 Study characteristics.
Author | Year | Country | Race | Geographic location | Inclusion period | Study type | Sample size, CA type | PNO,n (%) | hemoglobin sampling time | Outcome measurement | NOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assessment tool | Time point | |||||||||||
SOS-KANTOstudy group | 2012 | Japan | Yellow | Asia | 2002–2003 | mPOS | 137,OHCA | 103(75) | hospital arrival | CPC(1–2)34 CPC(3–5)103 | 1 month | 5 |
Aiham Albaeni | 2016 | USA | White | North America | 2004–2010 | sROS | 146,OHCA | 116(79) | ROSC | CPC(1–2)30 CPC(3–5)116 | – | 4 |
K. Ameloot | 2015 | Belgium | White | Europe | – | sROS | 82,CA | 39 | admission | CPC(1–2)7/21(33%) CPC(3–5)36/61(59%) | 6 month | 5 |
Federica Zama Cavicchi | 2020 | Belgium | White | Europe | 2007–2015 | sRos | 414,OHCA231 + IHCA | 257 | admission | CPC(1–2)157 CPC(3–5)257 | 3 month | 7 |
Andrew Wormsbecker | 2017 | Canada | White | North America | 2009–2014 | sRos | 118,OHCA + IHCA | 86 | Average hemoglobin | CPC(1–2)32 CPC(3–5)86 | Hospital discharge | 7 |
Chih-Hung Wang | 2016 | China | Yellow | Asia | 2006–2012 | sRos | 426IHCA | 372 | Average hemoglobin | CPC(1–2)54 CPC(3–5)372 | Hospital discharge | 5 |
Se Jong Oh | 2018 | Korea | Yellow | Asia | 2007–2013 | sROS | 295OHCA | 216 | hospital arrival | CPC(1–2)79 CPC(3–5)216 | 6 month | 5 |
Young Mo Cho MD | 2012 | Korea | Yellow | Asia | 2007–2010 | sROS | 117OHCA | 83 | hospital arrival | CPC (1–2) 34 CPC(3–5)83 | 1 month | 6 |
Kei Hayashida | 2014 | Japan | Yellow | Asia | 2011–2013 | mPOS | 495OHCA | 420 | hospital arrival | CPC (1–2) 75 CPC(3–5)420 | 3 month | 9 |
Adrien Bouglé | 2016 | France | White | Europe | 2012–2013 | sPOS | 43OHCA | 21 | Average hemoglobin | CPC (1–2) 22 CPC(3–5)21 | Hospital discharge | 7 |
Daesung Kim | 2018 | Korea | Yellow | Asia | 2009–2015 | sROS | 246OHCA | 159 | ROSC | CPC (1–2) 87 CPC(3–5)159 | Hospital discharge | 5 |
